---
pmid: '38288086'
title: OTUD3 suppresses the mTORC1 signaling by deubiquitinating KPTN.
authors:
- Li J
- Yang D
- Lin Y
- Xu W
- Zhao SM
- Wang C
journal: Front Pharmacol
year: '2023'
full_text_available: false
pmcid: PMC10822905
doi: 10.3389/fphar.2023.1337732
---

# OTUD3 suppresses the mTORC1 signaling by deubiquitinating KPTN.
**Authors:** Li J, Yang D, Lin Y, Xu W, Zhao SM, Wang C
**Journal:** Front Pharmacol (2023)
**DOI:** [10.3389/fphar.2023.1337732](https://doi.org/10.3389/fphar.2023.1337732)
**PMC:** [PMC10822905](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10822905/)

## Abstract

1. Front Pharmacol. 2024 Jan 15;14:1337732. doi: 10.3389/fphar.2023.1337732. 
eCollection 2023.

OTUD3 suppresses the mTORC1 signaling by deubiquitinating KPTN.

Li J(#)(1), Yang D(#)(2), Lin Y(1), Xu W(1), Zhao SM(1), Wang C(1).

Author information:
(1)Institutes of Biomedical Sciences, Obstetrics & Gynecology Hospital of Fudan 
University, Institutes of Metabolism and Integrative Biology, State Key 
Laboratory of Genetic Engineering, MOE Engineering Research Center of Gene 
Technology, School of Life Sciences, Fudan University, Shanghai, China.
(2)Department of Orthopedics, Shanghai Children's Hospital, School of Medicine, 
Shanghai Jiao Tong University, Shanghai, China.
(#)Contributed equally

Background: Ubiquitination and deubiquitination modifications play pivotal roles 
in eukaryotic life processes, regulating protein dynamics via the 
ubiquitin-proteasome pathway. Dysregulation can impact disease development, 
including cancer and neurodegenerative disorders. Increasing evidence highlights 
their role in tumorigenesis, modulating key proteins. OTUD3, a deubiquitinase, 
stabilizes PTEN, suppressing tumor growth by inhibiting PI3K-AKT signaling. Yet, 
further OTUD3 substrates remain underexplored. Methods: We employed the In vivo 
ubiquitination assay to investigate the ubiquitination role of OTUD3 on KPTN 
within the cellular context. Additionally, CRISPR/Cas9 editing and 
Immunofluorescence were utilized to study the impact of OTUD3 on the mTOR 
signaling pathway in cells. Furthermore, Cell proliferation assay and NMR were 
employed to explore the effects of OTUD3 on cellular growth and proliferation. 
Results: OTUD3 serves as a deubiquitinase for KPTN. OTUD3 interacts with KPTN, 
facilitated by the OTU domain within OTUD3. Further investigations confirmed 
KPTN's ubiquitination modification, primarily at lysine residue 49. 
Ubiquitination experiments demonstrated OTUD3's ability to mediate KPTN's 
deubiquitination without affecting its protein levels. This suggests KPTN's 
ubiquitination is a function-regulated, non-degradable modification. Under 
various amino acid starvation or stimulation conditions, overexpressing OTUD3 
reduces mTORC1 signaling activation, while knocking out OTUD3 further enhances 
it. Notably, OTUD3's regulation of mTORC1 signaling relies on its deubiquitinase 
activity, and this effect is observed even in PTEN KO cells, confirming its 
independence from PTEN, a reported substrate. OTUD3 also promotes GATOR1's 
lysosomal localization, a process requiring KPTN's involvement. Ultimately, 
OTUD3 affects cellular metabolic pool products by downregulating the mTORC1 
pathway, significantly inhibiting tumor cell growth and proliferation. 
Discussion: Our experiments shed light on an alternative perspective regarding 
the intrinsic functions of OTUD3 in inhibiting tumor development. We propose a 
novel mechanism involving KPTN-mediated regulation of the mTORC1 signaling 
pathway, offering fresh insights into the occurrence and progression of tumor 
diseases driven by related genes. This may inspire new approaches for drug 
screening and cancer treatment, potentially guiding future therapies for 
relevant tumors.

Copyright Â© 2024 Li, Yang, Lin, Xu, Zhao and Wang.

DOI: 10.3389/fphar.2023.1337732
PMCID: PMC10822905
PMID: 38288086

Conflict of interest statement: The authors declare that the research was 
conducted in the absence of any commercial or financial relationships that could 
be construed as a potential conflict of interest.
